Companies: 10,795·Total market cap: $144.5T

Cardio Diagnostics Holdings, Inc.

Cardio Diagnostics Holdings, Inc.

CDIONASDAQHealthcare● Active

$1.99

+$0.03(+1.53%)

Market Cap$4120544

P/E Ratio—

52W High$7.91

52W Low$0.97

Avg Volume170K

Open$2.05

Beta2.20

Cardio Diagnostics Holdings, Inc. (CDIO) Net Income & Profit History

Annual & trailing net income, net margin, YoY change, and peer profitability context.

CDIO · net income · updated Jun 9, 2026

Core profitability metrics

CDIO · net income · margin · TTM · CAGR

Net income was −$6.5M for FY2025 (fiscal year ending 2025-12-31), up 22.5% year-over-year. Net profit margin was -43832.5%.

FY2025 Net Income−$6.5M▲ +22.5% YoY

Trailing 12M (TTM)−$6.7Mtrailing 4 quarters sum

Net Profit Margin< −999%−$6.5M ÷ $14,825

YoY Change+22.5%—

5-Year CAGRN/AN/A — contains loss years

FormulaNet Margin = Net Income ÷ Revenue × 100TTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0

Source: FMP /income-statement · US GAAP · USDUpdated: Jun 9, 2026

Annual net income history

Net Income (bars) · Net Profit Margin % (line)

Net IncomeNet LossNet Margin %

▸ FMP /income-statement · Annual · CDIO net income history · CDIO profit margin

Annual net income data

CDIO · net income history · annual / quarterly

Fiscal YearNet IncomeYoY ChangeNet MarginRevenue

FY2025Loss−$6.5M▲ +22.5%-43832.5%$14,825

FY2024Loss−$8.4M▼ 0.1%-24028.2%$34,890

FY2023Loss−$8.4M▼ 79.7%-49087.8%$17,065

FY2022Loss−$4.7M▼ 651.2%-490630.0%$950

FY2021Loss−$620,448▼ 2.5%-68862.1%$901

Net income vs peers (Healthcare)

CDIO vs peers · net income

#CompanyNet IncomeYoYNet MarginRelative

#1

Cardio Diagnostics Holdings, Inc.YOU

CDIO

−$6.5M+22.5%-43832.5%

Loss

Johnson & Johnson

$26.80B+90.6%28.5%

Eli Lilly and Company

$20.64B+94.9%31.7%

UnitedHealth Group Incorporated

$12.06B-16.3%2.7%

$4.23B-1.2%6.9%

Healthcare · Sorted by Net Income · FMP /income-statementFull Net Income Rankings →

About Net Income & Methodology

Cardio Diagnostics Holdings, Inc. (CDIO) reported net income of −$6.5M for FY2025 (fiscal year ending 2025-12-31), up 22.5% year-over-year. The net profit margin was -43832.5% — meaning the company kept $-438.32 of every dollar of revenue as profit.

Cardio Diagnostics Holdings, Inc. has not yet achieved annual profitability based on available data (6 fiscal years). The company has reported net losses across all available periods.

Cardio Diagnostics Holdings, Inc.'s net profit margin was -43832.5% for FY2025, based on the latest annual results.

Investors sometimes search for "Cardio Diagnostics Holdings, Inc. net worth" — the company's market capitalization is a separate figure from CDIO net income. Data sourced from FMP /income-statement · US GAAP · USD.

Figures tie to SEC 10-K/10-Q and FMP /income-statement where noted.

Revenue Financial statements Earnings Forecast Price history Market cap Free cash flow

Frequently asked questions

CDIO net income · 4 questions

Cardio Diagnostics Holdings, Inc. is not currently profitable on an annual basis. The company reported a net loss of $6.5M for FY2025.

is CDIO profitabledoes CDIO make a profitCDIO profitabilityCDIO profitable company

▸ Source: FMP /income-statement · GAAP · Cardio Diagnostics Holdings, Inc. · Cardio Diagnostics Holdings, Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 9, 2026